ClinicalTrials.gov
ClinicalTrials.gov Menu

Hypokalemia in Hospitalized Patients for Heart Failure in the Therapeutic Cardiac Failure Unit (HYPIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03405051
Recruitment Status : Recruiting
First Posted : January 19, 2018
Last Update Posted : September 21, 2018
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Régional Metz-Thionville

Brief Summary:
Hypokalemia is very common in heart failure patients. Deleterious effects have been report on the cardiovascular system. Most of the clinical data concerning this ionic trouble are based on post-hoc study and some findings seemed disjointed.

Condition or disease
Heart Failure

Detailed Description:
This study tried to describe hypokalemia impact during hospital stay in hospitalized patients with heart failure and particularly on mortality and re-hospitalization.

Study Type : Observational
Estimated Enrollment : 250 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Hypokalemia in Hospitalized Patients for Heart Failure in the Therapeutic Cardiac Failure Unit: Morbidity-mortality Impact
Actual Study Start Date : November 15, 2017
Estimated Primary Completion Date : November 2018
Estimated Study Completion Date : February 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure




Primary Outcome Measures :
  1. Composite of death and re-hospitalization [ Time Frame: Month 3 ]
    The number of death for any reason and re-hospitalization for congestive heart failure


Secondary Outcome Measures :
  1. Death [ Time Frame: Month 3 ]
    Percentage of death for any reason

  2. Re-hospitalization [ Time Frame: Month 3 ]
    Percentage of re-hospitalization for congestive heart failure

  3. Length of stay [ Time Frame: Month 3 ]
    Days spent at the hospital

  4. Incidence of hypokalemia [ Time Frame: Month 3 ]
    Percentage of incidence during the stay of hypokalemia

  5. Prevalence of hypokalemia [ Time Frame: Month 3 ]
    Percentage of initial prevalence during the stay of hypokalemia



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients with congestive heart failure admitted to the Heart Failure Unit in the Mercy hospital (CHR Metz-Thionville).
Criteria

Inclusion Criteria:

  • Hospitalized patient in the Therapeutic Cardiac Failure Unit in the CHR Metz-Thionville
  • Patient with congestive heart failure

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03405051


Contacts
Contact: Noura Zannad, MD +33387553231 n.zannad@chr-metz-thionville.fr
Contact: Sandra Marchionni +33387557750 s.marchionni@chr-metz-thionville.fr

Locations
France
CHR Metz-Thionville Recruiting
Metz, France, 57085
Contact: Nadia OUAMARA    +33387557752    n.ouamara@chr-metz-thionville.fr   
Sponsors and Collaborators
Centre Hospitalier Régional Metz-Thionville

Responsible Party: Centre Hospitalier Régional Metz-Thionville
ClinicalTrials.gov Identifier: NCT03405051     History of Changes
Other Study ID Numbers: 2017-03Obs-CHRMT
First Posted: January 19, 2018    Key Record Dates
Last Update Posted: September 21, 2018
Last Verified: December 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Centre Hospitalier Régional Metz-Thionville:
hypokalemia
cardiac failure

Additional relevant MeSH terms:
Heart Failure
Hypokalemia
Potassium Deficiency
Heart Diseases
Cardiovascular Diseases
Water-Electrolyte Imbalance
Metabolic Diseases
Deficiency Diseases
Malnutrition
Nutrition Disorders